Zhaowei Hua

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Neuroinflammation, Hyperphosphorylated Tau, Diffuse Amyloid Plaques, and Down-Regulation of the Cellular Prion Protein in Air Pollution Exposed Children and Young Adults

Michael Kavanaugh, Michelle L. Block, Amedeo D’Angiulli et al. · Journal of Alzheimer s Disease · 2012 · 278 citations

Life Sciences, Neurobiology, Neuroscience +17

Pevonedistat (<scp>MLN</scp>4924), a First‐in‐Class <scp>NEDD</scp>8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study

Ronan Swords, Harry P. Erba, Daniel J. DeAngelo et al. · British Journal of Haematology · 2015 · 234 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

Jatin J. Shah, Andrzej Jakubowiak, Owen A. O’Connor et al. · Clinical Cancer Research · 2015 · 190 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study

P. Ventura, Herbert L. Bonkovsky, Laurent Gouya et al. · Liver International · 2021 · 77 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14